Furthermore, the long COVID group differed from ME/CFS patients in having lower levels of TSP-1, serpin E1 (PAI-1), E-selectin, IL-1β, IL-4, and IL-6, suggesting a lower level of inflammation within the former cohort. The gene discussed is THBS1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.